Justin Ritz

7PUBLICATIONS
26CO-AUTHORS
Infectious diseasesCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)VenereologyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 17, 2024
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19.

Nikolaus Jilg, Mark J Giganti, Kara W Chew

|Jan 04, 2024
Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials.

McNeil Ngongondo, Justin Ritz, Michael D Hughes

|Apr 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.

Teresa H Evering, Kara W Chew, Mark J Giganti

|Feb 21, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.

Rinki Deo, Manish C Choudhary, Carlee Moser

|Jan 19, 2023
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.

Kara W Chew, Carlee Moser, Eric S Daar

|Oct 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial.

Manish C Choudhary, Kara W Chew, Rinki Deo

Pageof 2

Frequent Collaborators

6 joint publications

Kara W Chew

6 joint publications

Judith S Currier

6 joint publications

Davey Smith

5 joint publications

Carlee Moser